Related Experiment Video
Updated: Jul 13, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Modelling the hepatitis C virus epidemic in Australia
Karina Razali1, Hla Hla Thein, Jane Bell
1National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia. krazali@nchecr.unsw.edu.au
This study uses mathematical models to track the history of hepatitis C infections in Australia from 1960 to 2005. Researchers found that new infections peaked in 1999 before dropping, likely due to changes in heroin availability. While new cases have decreased, the total number of people living with the virus continues to rise.
Area of Science:
- Epidemiology and public health research regarding hepatitis C virus transmission dynamics
- Mathematical modeling in infectious disease control
Background:
No prior work had resolved the full scope of hepatitis C virus trends in Australia across several decades. That uncertainty drove researchers to investigate how shifting drug supply patterns influenced infection rates. Prior research has shown that injecting drug use remains the primary driver for viral transmission in this region. This gap motivated a comprehensive analysis of historical data to clarify incidence patterns. It was already known that heroin availability underwent significant fluctuations during the early two-thousands. That historical shift created a unique opportunity to examine its impact on public health outcomes. No prior work had resolved the specific contribution of different transmission groups to the total burden. That uncertainty drove the need for updated estimates covering the period from 1960 through 2005.
Purpose Of The Study:
The aim of this study was to update historical estimates of infection incidence and prevalence in Australia. Researchers sought to clarify how changes in heroin supply influenced the trajectory of the epidemic. The study addressed the need for a clearer understanding of transmission dynamics between 1960 and 2005. Investigators focused on quantifying the relative impact of various exposure groups on the total burden. This work aimed to provide a robust mathematical assessment of how injecting drug use drives viral spread. The researchers intended to evaluate the coincidence between drug availability and infection rates. This effort was motivated by the lack of updated data regarding long-term epidemic trends. The study sought to provide a comprehensive overview of the virus's impact on the Australian population.
Main Methods:
Review Approach framing involved utilizing mathematical simulations to evaluate infection trends across multiple decades. Researchers gathered data on injecting drug use patterns to inform their primary calculations. Review Approach framing required applying a natural history framework to estimate total population prevalence. Investigators categorized individuals into distinct groups based on their specific exposure risks. Review Approach framing utilized historical records to track changes from 1960 until 2005. Analysts incorporated migrant status as a secondary variable to refine their incidence estimates. Review Approach framing relied on indicators of substance use to determine the size of the at-risk population. Investigators performed these calculations to generate updated estimates of both incidence and prevalence.
Main Results:
Key Findings From the Literature framing indicates that new infections reached a maximum of 14,000 cases in 1999. Key Findings From the Literature framing shows that incidence dropped to 9,700 cases by 2005. Key Findings From the Literature framing reveals that 88.7% of new cases originated from injecting drug use. Key Findings From the Literature framing notes that migrants accounted for 7.2% of new infections. Key Findings From the Literature framing reports that other transmission routes contributed 4.1% to the total incidence. Key Findings From the Literature framing confirms that 264,000 people were antibody positive in 2005. Key Findings From the Literature framing highlights that the decline in new cases coincided with reduced heroin availability. Key Findings From the Literature framing observes that the total number of infected individuals continues to grow.
Conclusions:
Synthesis and Implications framing suggests that the peak in viral transmission occurred during the final year of the twentieth century. Authors propose that the subsequent reduction in new cases aligns with decreased heroin access. Synthesis and Implications framing indicates that injecting drug use remains the dominant pathway for new infections. Authors propose that migrant populations and other routes represent smaller fractions of the total incidence. Synthesis and Implications framing highlights that the total number of individuals living with the virus is still rising. Authors propose that these findings underscore the persistent burden of the disease despite recent declines in transmission. Synthesis and Implications framing notes that mathematical projections provide a clearer picture of long-term epidemic trajectories. Authors propose that these models are valuable for informing future public health strategies regarding viral management.
Frequently Asked Questions
The researchers propose that the peak of 14,000 annual infections in 1999 dropped to 9,700 by 2005. This decline is linked to a reduction in heroin availability, which decreased the frequency of injecting drug use across the population.
The investigators applied a natural history model to estimate prevalence. This tool integrates data on injecting drug use indicators, migrant status, and other exposure routes to simulate the progression of the epidemic over four decades.
Mathematical simulations were necessary to account for diverse transmission pathways. Without these calculations, it would be impossible to distinguish the relative contributions of injecting drug use, which accounts for 88.7% of cases, from the 7.2% attributed to migrant populations.
The researchers utilized indicators of injecting drug use to estimate the number of active users. This data type serves as a proxy for identifying the population at risk, allowing for the calculation of seroconversion rates over time.
The study measured the number of people who were antibody positive. By 2005, this figure reached an estimated 264,000 individuals, reflecting the cumulative burden of the virus despite the observed decrease in annual new cases.
The authors propose that while new infections have decreased, the total number of people living with the virus will continue to rise. This implication suggests that long-term healthcare planning must account for a growing population of infected individuals.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
